These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 8689285

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation of a new solid formulation of calcium and vitamin D in institutionalized elderly subjects. A randomized comparative trial versus separate administration of both constituents.
    Sebert JL, Garabedian M, Chauvenet M, Maamer M, Agbomson F, Brazier M.
    Rev Rhum Engl Ed; 1995 Apr; 62(4):288-94. PubMed ID: 7606425
    [Abstract] [Full Text] [Related]

  • 3. Follow-up study of biological parameters in elderly institutionalized patients more than one year after discontinuation of calcium-vitamin D supplementation.
    Sebert JL, Fardellone P, Maamer M, Agbomson F, Brazier M, Garabedian M.
    Rev Rhum Engl Ed; 1996 Apr; 63(7-8):498-501. PubMed ID: 8896064
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease.
    Lindberg J, Martin KJ, González EA, Acchiardo SR, Valdin JR, Soltanek C.
    Clin Nephrol; 2001 Oct; 56(4):315-23. PubMed ID: 11680662
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
    Blair D, Byham-Gray L, Lewis E, McCaffrey S.
    J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of vitamin D levels on postoperative calcium requirements, symptomatic hypocalcemia, and parathormone levels following parathyroidectomy for primary hyperparathyroidism.
    Press D, Politz D, Lopez J, Norman J.
    Surgery; 2011 Dec; 150(6):1061-8. PubMed ID: 22136822
    [Abstract] [Full Text] [Related]

  • 15. Diagnosing hypovitaminosis D: serum measurements of calcium, phosphate, and alkaline phosphatase are unreliable, even in the presence of secondary hyperparathyroidism.
    Smith GR, Collinson PO, Kiely PD.
    J Rheumatol; 2005 Apr; 32(4):684-9. PubMed ID: 15801026
    [Abstract] [Full Text] [Related]

  • 16. High prevalence of vitamin D deficiency among Ethiopian women immigrants to Israel: exacerbation during pregnancy and lactation.
    Fogelman Y, Rakover Y, Luboshitzky R.
    Isr J Med Sci; 1995 Apr; 31(4):221-4. PubMed ID: 7721559
    [Abstract] [Full Text] [Related]

  • 17. A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia.
    Collins N, Maher J, Cole M, Baker M, Callaghan N.
    Q J Med; 1991 Feb; 78(286):113-22. PubMed ID: 1851568
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
    Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C.
    Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
    [Abstract] [Full Text] [Related]

  • 20. Secondary hyperparathyroidism in primary osteoporosis and osteopenia: optimizing calcium and vitamin D intakes to levels recommended by expert panels may not be sufficient for correction.
    Yendt ER, Kovacs KA, Jones G.
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):855-63. PubMed ID: 18419790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.